Form 4 for EDIT Editas Medicine, Inc.
Accepted 2023-07-21 00:00:00 ET · period of report 2023-07-19 · accession 0001415889-23-011382 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-21 | 2023-07-19 | EDIT | Mei Baisong | SVP, Chief MEDICAL Off | S - Sale | $8.80 | -4,317 | 72.1K | -6% | -$38.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-19 | S | D | 4,317 | $8.80 | 72,055 | D | — | — |